We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Wants Help Devising Action Plan To Boost Patient Subgroups in Research
FDA Wants Help Devising Action Plan To Boost Patient Subgroups in Research
August 28, 2013
A little over a year after Congress passed the FDA Safety and Innovation Act, the agency is asking stakeholders for feedback on ways to include more patient subpopulations in clinical trials in a bid to boost personalized medical care.